Description
Peptide for tissue-protection and inflammatory pathway research
ARA-290 is a synthetic peptide derived from the helix B region of erythropoietin (EPO), investigated for its interaction with tissue-protection signaling pathways without the erythropoietic activity associated with full-length EPO. Researchers commonly study ARA-290 in experimental models involving inflammatory signaling, cellular stress response, and tissue-recovery mechanisms.
Unlike broader regenerative peptides focused primarily on structural tissue remodeling, ARA-290 is primarily researched for receptor-mediated protective signaling and inflammatory pathway modulation. Particular interest exists around its interaction with innate repair mechanisms, microvascular dynamics, and neuroinflammatory research environments.
Due to its selective signaling profile, ARA-290 occupies a distinct position within the healing & recovery research category, often explored in models involving nerve-related tissue response, epithelial stress signaling, and peptide-mediated cellular protection pathways.
Research applications (investigational)
ARA-290 has been investigated in preclinical and experimental settings for its involvement in:
• Tissue-protection signaling pathways
• Inflammatory pathway modulation
• Neuroinflammatory and nerve-response research
• Cellular stress-response mechanisms
• Microvascular and endothelial signaling models
• Peptide-mediated recovery pathway investigation
• Innate repair and protective signaling dynamics
These areas reflect ongoing scientific investigation into peptide-mediated protective mechanisms rather than established applications.
Product characteristics
Purity: ≥99% (HPLC-tested)
Appearance: Lyophilized white/off-white powder
Molecular formula: C51H84N16O21
Molecular weight: 1257.31
Sequence: Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
Storage: store lyophilized powder at -20°C, protect from light and moisture. Reconstituted solution should be kept at 2–8°C and used within a short period.
Why choose our ARA-290?
- High purity verified by HPLC.
- Produced in GMP-compliant facilities under strict QC protocols.
- Each batch carefully lab tested after production (Certificate of Analysis available under product pictures).
- Freeze-dried (lyophilized) for maximum stability and extended shelf life.
- Sealed in sterile vials, ready for reconstitution.
Reconstitution: Must be reconstituted using appropriate laboratory technique. Due to its physicochemical properties, ARA-290 requires reconstitution with buffered saline. Inadequate pH conditions or improper handling may result in incomplete dissolution or a whitish/opalescent appearance.
Selected research references
- Brines M et al. ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves tissue-protective signaling. Proceedings of the National Academy of Sciences, 2008.
- Brines M et al. Erythropoietin-derived peptide protection without hematopoietic activity. Molecular Medicine, 2004.
- Dahan A et al. ARA-290 and inflammatory pathway research in neuropathic models. Molecular Pain, 2013.
- Heij L et al. ARA-290 in small fiber neuropathy research models. Journal of Translational Medicine, 2012.
Related research context
ARA-290 belongs to the Healing & recovery peptide research category, with stronger emphasis on tissue-protection and inflammatory signaling pathways.
Researchers investigating complementary recovery and cellular-response models may also examine:
• KPV — inflammatory signaling and epithelial pathway research
• BPC-157 — tissue signaling and angiogenesis research
• TB-500 (Thymosin β4) — migration and cytoskeletal pathway investigation
• GHK-Cu — extracellular remodeling and skin-related peptide signaling
For broader context, see the Healing & recovery research guide.
NOTE: This is for educational reference only and does not constitute medical advice.
Disclaimer:
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.










Reviews
There are no reviews yet.